#covid-19 — Sunday, February 01, 2026 (2 items)
| 0 | ℹ |
Antiviral efficacy of oral ensitrelvir versus oral ritonavir-boosted nirmatrelvir in COVID-19 (PLATCOV): an open-label, phase 2, randomised, controlled, adaptive trial.
(linkinghub.elsevier.com)
|
Lancet Infectious Diseases 2026-02-01 | #pharmacokinetics #covid-19 #clinical trial #antiviral | |
| 0 | ℹ |
Life-Threatening SARS-CoV-2-Associated Encephalopathy and Multiorgan Failure in Children, Asia and Oceania, 2022-2024.
(wwwnc.cdc.gov)
|
Emerging Infectious Diseases 2026-02-01 | #covid-19 #inflammation #pediatric #encephalopathy #multiorgan failure |